Compare Graha Andrasentra Propertindo Tbk. (JGLE) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Graha Andrasentra Propertindo Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Graha Andrasentra Propertindo Tbk. trades at Rp77 (market cap 1.76T, 344.1M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Graha Andrasentra Propertindo Tbk. is far larger — about 16.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| JGLE | SCPI | |
|---|---|---|
Market Cap | 1.76T | 104.4B |
Volume | 344.1M | — |
Lot | 3.44M | — |
Turnover | 26.74B | — |
Average Price | 77.7 | — |
Value | 26.74B | — |
Indicative Equilibrium Price | 77 | — |
Indicative Equilibrium Volume | 62.24K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Graha Andrasentra Propertindo Tbk.
PT Graha Andrasentra Propertindo Tbk (the Company) was established under its original name of PT Aliyah Pancahafat based on Notarial Deed No. 42 dated Juny 15, 1988 of Yetty Taher, S.H.
Read more on JGLE →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
